Skip to main content
. 2017 Oct 26;59(1):14–24. doi: 10.1194/jlr.M076752

Fig. 3.

Fig. 3.

Prognostic value of miR-19b-1 in CRC stage II patients. Kaplan-Meier survival curves for CRC patients showing correlation between DFS in stage II patients and the expression levels of miR19b-1-5p (A) or miR19-b-3p (B), or in stage III patients and the expression levels of miR19b-1-5p (C) or miR19-b-3p (D). E: Univariate and multivariate Cox regression analyses. (CRC stage II patients n = 80, 17.50% of recurrence; CRC stage III patients n = 46, 39.13% of recurrence).